Clinical and bacteriological study of sparfloxacin on bacterial prostatitis
Sparfloxacin (SPFX), a new oral quinolone antimicrobial, was studied for the bacterial response, pharmacokinetics and clinical efficacy in the treatment of bacterial prostatitis. The minimum inhibitory concentration (MIC) values for 48 strains isolated from expressed prostatic secretion were measure...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 1 vom: 31. Jan., Seite 121-8 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1992
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Anti-Infective Agents Fluoroquinolones Quinolones sparfloxacin Q90AGA787L |